Device / Technology News

RSS

Advantages of Helicos BioSciences' single molecule sequencing technology presented

Helicos BioSciences Corporation announced today that, as previously disclosed, it has posted a presentation on its website regarding the advantages of Helicos’ single molecule sequencing technology in clinical diagnostics.

4 Dec 2009

Usefulness of heart rate variability as a diagnostic for identifying dysfunction established

According to Dr. Daniel Weiss, a recent study of heart rate autonomic markers, and cardiac mortality published in the November issue of Heart Rhythm provides additional support for the usefulness of heart rate variability as a diagnostic for identifying dysfunction (neuropathy in diabetics and others) and cardiovascular mortality, including fatal arrhythmia or sudden cardiac death.

4 Dec 2009

Instacare announces initial parallel marketing strategy for its cell phone centric products

Instacare Corp., a leading provider of life-saving prescription drugs, home testing products for the chronically ill, a leading fulfillment provider of direct to patient diabetes programs and a leading developer of e-health technology and revolutionary cell phone centric technologies and products announced today its intent to file multiple updated and enhanced patent and trademark applications covering its cell phone centric technologies with the United States Patent and Trademarks Office.

4 Dec 2009

ShowNearby's PathFinder and Product Locator tools adopted by First Aid

First Aid Corps, a worldwide volunteer coalition, has adopted worldwide location-based content facilitator ShowNearby's PathFinder and Product Locator tools to reduce sudden cardiac arrest deaths in Singapore.

4 Dec 2009

GE Centricity Perioperative Anesthesia recognized as top anesthesia information management solution

GE’s Centricity Perioperative Anesthesia has been recognized as the top anesthesia information management solution in a special report from KLAS, an industry analyst firm (www.KLASresearch.com).

4 Dec 2009

Text messaging technology has important implications for public health initiatives, finds study

A recent study conducted by the Center for Connected Health, a division of Partners HealthCare, found that text messaging is an innovative, low-cost and effective way to improve the daily use of sunscreen, and this technology may have important implications for larger-scale public health initiatives.

4 Dec 2009

RemedyMD launches first nationwide Pediatric Diabetes Registry

RemedyMD (www.RemedyMD.com), the leading provider of Disease Registry software, today announced the first nationwide Pediatric Diabetes Registry. The new registry was developed to help clinicians and researchers identify which interventions are most appropriate for specific patient populations.

4 Dec 2009

Alkermes licenses Medifusion technology to develop TNF receptor-Fc fusion protein

Alkermes, Inc. and Acceleron Pharma, Inc. today announced that Alkermes has licensed a proprietary long-acting Fc fusion technology platform, called the Medifusion™ technology, which is designed to extend the circulating half-life of proteins and peptides.

4 Dec 2009

Presbia's Flexivue lens obtains CE certification

Presbia, a leader in the development and marketing of a surgical solution for presbyopia, today announced its Flexivue™ micro-lens received CE certification for its products sold within the European Economic Area (EEA). Specifically, the CE mark certifies that Flexivue™ has met European Union consumer safety, health and environmental requirements.

4 Dec 2009

Shire voluntarily recalls specific lots of its Daytrana ADHD patches

Shire plc, the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot of the Attention-Deficit/Hyperactivity Disorder (ADHD) patch Daytrana®. Shire is taking this action because some Daytrana patches do not meet or in the future may not meet their release liner removal specification, and as a result, patients and caregivers could have difficulty removing the liners.

3 Dec 2009

Caliper Life Sciences releases Living Image 4.0 software for its IVIS in vivo imaging systems

Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today introduced Living Image 4.0 software for IVIS® in vivo imaging systems. Living Image software drives the more than 800 Caliper IVIS systems currently installed in laboratories worldwide.

3 Dec 2009

NIMS’ Exer-Rest acceleration therapeutic platform granted Canadian Patent

Non-Invasive Monitoring Systems, Inc. announced that the Canadian Patent Office issued Patent number 2,534,302 to NIMS on October 20, 2009. The patent, entitled “Reciprocating Movement Platform for the External Addition of Pulses to the Fluid Channels of a Subject”, relates to the comprehensively researched technology underlying NIMS’ Exer-Rest acceleration therapeutic platform.

3 Dec 2009

Spectranetics receives FDA clearance for its new VisiSheath Dilator Sheath device

Spectranetics Corporation today announced it has received Food and Drug Administration (FDA) 510(k) clearance for its new VisiSheathTM Dilator Sheath device. This expands the market for VisiSheath, which recently also received CE Mark approval in Europe.

3 Dec 2009

GTSI named value-added reseller of the Intel Health Guide RPM solution

GTSI Corp. an enterprise technology solutions and services provider was recently named a value-added reseller to deliver the Intel® Health Guide, a comprehensive, next-generation remote patient monitoring (RPM) solution that combines an in-home patient device, the Intel Health Guide PHS6000, with the Intel® Care Management Suite, an online interface that allows clinicians to monitor patients and remotely manage care.

3 Dec 2009

Milestone Scientific announces new joint venture with two PRC pharmaceutical companies

Milestone Scientific Inc., the recognized leader in advanced injection technologies, today announced that it had entered into a joint venture with China National Medicines Corporation Ltd. (d/b/a "Sinopharm") and Yichang Humanwell Pharmaceutical Co. Ltd., both incorporated in the People's Republic of China (the "PRC"), to develop orthopedic and epidural drug delivery instruments.

3 Dec 2009

New health IT grants to be 'models' for the nation

The federal government will offer $235 million in grants for communities to upgrade and improve their health information technology, The Dallas Morning News reports. Only organizations that are already using health IT are eligible. Health secretary Kathleen Sebelius said, "Our hope is that the communities will become models for the rest of the country" (Roberson, 12/2).

3 Dec 2009

CLC bio, imaGenes announce collaboration in high-throughput sequencing analyses

Today, the leading provider of High-Throughput Sequencing analysis solutions, CLC bio, announced that they're collaborating with premier German sequencing service provider, imaGenes, to better support the fast growing German market of high-throughput sequencing analyses. imaGenes, will provide all customers receiving Next Generation Sequencing data with a temporary license for CLC Genomics Workbench for assembly and downstream sequence analyses.

3 Dec 2009

Cielo MedSolutions, DrFirst partner to provide a comprehensive e-prescribing solution

Cielo MedSolutions today announced a new partnership with DrFirst to provide comprehensive e-prescribing functionality to practices using the company's Cielo Clinic clinical quality management system. The fully integrated e-prescribing solution will enable customers to improve prescribing safety and medical practice efficiency.

3 Dec 2009

Enrollment closed early in Cubist Pharmaceuticals' ecallantide Phase 2 program

Cubist Pharmaceuticals, Inc. today announced the early closing of enrollment in its ecallantide Phase 2 program. Ecallantide, in development as therapy to reduce bleeding in on-pump cardiac surgery, is now known as CB-500,929. After a regularly scheduled review meeting, the Data Safety Monitoring Board (DSMB) contacted the company to recommend a temporary suspension in enrollment in one of the CB-500,929 trials, CONSERV-2.

3 Dec 2009

Psynova Neurotech, Roche collaborate in development of diagnostic immunoassays for schizophrenia treatment

Rules-Based Medicine, Inc. (RBM) today announced that Psynova Neurotech Limited (Cambridge UK), a majority-owned subsidiary of RBM, has executed an exclusive research and licensing agreement with Roche to collaborate on the discovery, development, validation and commercialization of diagnostic immunoassays to aid the clinical development and commercial differentiation of novel treatments for schizophrenia.

3 Dec 2009

Device / Technology News

Advantages of Helicos BioSciences' single molecule sequencing technology presented

Usefulness of heart rate variability as a diagnostic for identifying dysfunction established

Instacare announces initial parallel marketing strategy for its cell phone centric products

ShowNearby's PathFinder and Product Locator tools adopted by First Aid

GE Centricity Perioperative Anesthesia recognized as top anesthesia information management solution

Text messaging technology has important implications for public health initiatives, finds study

RemedyMD launches first nationwide Pediatric Diabetes Registry

Alkermes licenses Medifusion technology to develop TNF receptor-Fc fusion protein

Presbia's Flexivue lens obtains CE certification

Shire voluntarily recalls specific lots of its Daytrana ADHD patches

Caliper Life Sciences releases Living Image 4.0 software for its IVIS in vivo imaging systems

NIMS’ Exer-Rest acceleration therapeutic platform granted Canadian Patent

Spectranetics receives FDA clearance for its new VisiSheath Dilator Sheath device

GTSI named value-added reseller of the Intel Health Guide RPM solution

Milestone Scientific announces new joint venture with two PRC pharmaceutical companies

New health IT grants to be 'models' for the nation

CLC bio, imaGenes announce collaboration in high-throughput sequencing analyses

Cielo MedSolutions, DrFirst partner to provide a comprehensive e-prescribing solution

Enrollment closed early in Cubist Pharmaceuticals' ecallantide Phase 2 program

Psynova Neurotech, Roche collaborate in development of diagnostic immunoassays for schizophrenia treatment

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News